Actively Recruiting

Age: 18Years +
All Genders
ID05057403

UK Imaging Diabetes Study Seeing Diabetes Clearly

Led by Perspectum · Updated on 2025-12-05

1000

Participants Needed

12

Research Sites

N/A

Total Duration

On this page

Sponsors

P

Perspectum

Lead Sponsor

M

Moorfields Eye Hospital NHS Foundation Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting a prospective, observational study to assess the health of multiple organs in adults with type 2 diabetes who have no history of cardiovascular disease. The goal is to understand if detailed MRI measurements can help predict future clinical events over a 5-year period. Participants include adults diagnosed with type 2 diabetes, especially those diagnosed within the last three years. Participants will undergo no changes to their standard medical care. The study involves two main visits within one month: the first includes body measurements and collection of blood and urine samples for routine diabetes checks, and the second involves a multi-organ, multiparametric MRI scan. Data from these visits, along with access to medical records, will be used to monitor disease progression and predict outcomes over 1, 3, and 5 years. Throughout the 5-year study, researchers will collect MRI metrics, clinical outcomes, and lab samples to evaluate diabetes progression. Participants consent to access their hospital and mortality records for event tracking. The primary outcome is the rate of major cardiovascular events three years after the baseline MRI. Secondary outcomes include kidney, eye, liver, cancer, and mortality events assessed at 1, 3, and 5 years. The study requires only a short period of active participation, with long-term follow-up through record review.

CONDITIONS

Brief Title

UK Imaging Diabetes Study Seeing Diabetes Clearly

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female at least 18 years of age
  • Diagnosed with type 2 diabetes, with or without diabetic retinopathy
  • Willing and able to give informed consent for participation
Not Eligible

You will not qualify if you...

  • History of cardiovascular events in the past 12 months, including myocardial infarction, ischemic stroke, unstable angina, heart surgery, or transient ischemic attack
  • Contraindications to MRI such as pregnancy, extensive tattoos, pacemaker, shrapnel injury, or severe claustrophobia
  • Known autoimmune hepatitis, viral hepatitis, Wilson's disease, or significant structural kidney abnormalities
  • Known alcohol dependency
  • Any other significant disease or disorder that may put the participant at risk or affect participation as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 month

Participants complete baseline assessments including anthropometric measurements, blood and urine samples, and a multi-organ MRI scan to collect data on type 2 diabetes and organ health.

2 visits (in-person) within 28 days of screening

Long-term Monitoring

Duration - 5 years

Participants' medical records are accessed periodically to monitor health outcomes related to diabetes over 5 years following baseline assessments.

Medical record reviews at 1, 3, and 5 years after baseline

Trial Site Locations

Total: 12 locations

1

Woodlands Medical Centre

Didcot, Oxfordshire, United Kingdom, OX11 0BB

Actively Recruiting

2

Eynsham Medical Centre

Eynsham, Oxfordshire, United Kingdom, OX29 4QB

Actively Recruiting

3

White Horse Medical Practice

Farringdon, Oxfordshire, United Kingdom, SN7 7YU

Actively Recruiting

4

Windrush Medical Practice

Witney, Oxfordshire, United Kingdom, OX26 6JS

Actively Recruiting

5

The House Partnership

Redhill, Surrey, United Kingdom, RH1 1EB

Actively Recruiting

6

Swansea Bay University Health Board

Baglan, Swansea, United Kingdom, SA12 7BR

Not Yet Recruiting

7

University Hospitals of Liverpool Group

Liverpool, United Kingdom, L9 7AL

Actively Recruiting

8

Moorfields Eye Hospital NHS Foundation Trust

London, United Kingdom

Enrolling by Invitation

9

The Manor Group

Oxford, United Kingdom, OX3 9BP

Actively Recruiting

10

Hedena Health

Oxford, United Kingdom, OX3 9JA

Actively Recruiting

11

St Bartholomew and Hollow Way Medical Practice

Oxford, United Kingdom, OX4 1XB

Actively Recruiting

12

Oxford Community Diagnostic centre

Oxford, United Kingdom, OX42LL

Actively Recruiting

Loading map...

Research Team

S

Soubera Rymall, MSc

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Causative Role for Amylin in Diabetic Peripheral Neuropath...

Type2 Diabetes

Actively Recruiting

2 locations

Brain Health Across the Metabolic Spectrum in Youth at Risk ...

Type2 Diabetes

Actively Recruiting

2 locations

Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gast...

Type2 Diabetes

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here